- Article metrics
- Last updated: Fri, 3 Apr 2026 5:20:33 Z
Cost-effectiveness of CDK4/6 inhibitors for second-line HR+/HER2− advanced or metastatic breast cancer in China
Access & Citations
-
- 5399
- Article Accesses
-
- 7
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
